At Medlogical Innovations, we take pride in being at the forefront of medical technological advancement. We are committed to producing medical devices that are not only cutting edge but logical in their application and use by physicians world wide. The quality of our goods and our care for those who use our products are of paramount importance. This commitment to spearhead excellence in quality and care is what drives our company.
Magnetic resonance image‐guided focal laser ablation in clinically localized prostate cancer: safety and efficacy
FLA is safe with no impact on urinary and sexual functions at 18 months follow-up. Oncologic control is encouraging. Larger scale studies and longer follow-up are required.
Contemporary treatments in prostate cancer focal therapy
Radical treatments for prostate cancer are associated with significant morbidity, including incontinence and erectile dysfunction. Advances in the field of prostate MRI and desire to reduce treatment morbidities have led to a rapid growth in focal treatments for prostate cancer. Here, we review novel focal prostate cancer treatments and their associated recent clinical data, with a particular focus on data reported within the last 24 months.
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
Clinically significant nonmetastatic prostate cancer (PCa) is currently treated using whole-gland therapy. This approach is effective but can have urinary, sexual, and rectal side effects.